- Open Access
Isolation and genetic characterization of human coronavirus NL63 in primary human renal proximal tubular epithelial cells obtained from a commercial supplier, and confirmation of its replication in two different types of human primary kidney cells
© Lednicky et al.; licensee BioMed Central Ltd. 2013
- Received: 31 May 2013
- Accepted: 10 June 2013
- Published: 27 June 2013
Cryopreserved primary human renal proximal tubule epithelial cells (RPTEC) were obtained from a commercial supplier for studies of Simian virus 40 (SV40). Within twelve hrs after cell cultures were initiated, cytoplasmic vacuoles appeared in many of the RPTEC. The RPTEC henceforth deteriorated rapidly. Since SV40 induces the formation of cytoplasmic vacuoles, this batch of RPTEC was rejected for the SV40 study. Nevertheless, we sought the likely cause(s) of the deterioration of the RPTEC as part of our technology development efforts.
Adventitious viruses in the RPTEC were isolated and/or detected and identified by isolation in various indicator cell lines, observation of cytopathology, an immunoflurorescence assay, electron microscopy, PCR, and sequencing.
Cytomegalovirus (CMV) was detected in some RPTEC by cytology, an immunofluorescence assay, and PCR. Human Herpesvirus 6B was detected by PCR of DNA extracted from the RPTEC, but was not isolated. Human coronavirus NL63 was isolated and identified by RT-PCR and sequencing, and its replication in a fresh batch of RPTEC and another type of primary human kidney cells was confirmed.
At least 3 different adventitious viruses were present in the batch of contaminated RPTEC. Whereas we are unable to determine whether the original RPTEC were pre-infected prior to their separation from other kidney cells, or had gotten contaminated with HCoV-NL63 from an ill laboratory worker during their preparation for commercial sale, our findings are a reminder that human-derived biologicals should always be considered as potential sources of infectious agents. Importantly, HCoV-NL63 replicates to high titers in some primary human kidney cells.
Cell lines and primary cells obtained from commercial suppliers or through inter-laboratory transfer can contain adventitious (i.e., contaminating) viruses. This happens primarily because cytopathic effects (CPE) are not always apparent in virus-infected cell cultures, and consequently, the cells are unwittingly sold or transferred between laboratories . The adventitious viruses that are encountered in cell cultures often stem from bovine serum that is used to supplement cell growth media, and include: bovine viral diarrhea virus (BVDV) [1–6], bovine polyomavirus [1, 7, 8], bovine parvovirus [1, 9–11] (J. Lednicky, unpublished), and bovine herpes viruses [1, 12–15]. Unintentional contamination of cultured cells by these serum-derived viruses has obvious consequences not only with regard to data generation, but also because it exerts a toll on time wasted in the performance of laboratory work, and the costs thereof. Other common sources of contaminating viruses are: (a) laboratory workers, and (b) animal-sourced enzymes (such as porcine trypsin) and (c) other biologicals that are used for cell culture . Examples of viruses that stem from porcine trypsin that have recently been found as contaminants of many cell lines including those used for vaccine production are Torque teno sus virus (TTSuV), a member of the family Anelloviridae, and Porcine circoviruses 1 and 2 (PCV1 and PCV2) [1, 16–20]. Anelloviruses and circoviruses are relatively small viruses with single-stranded, circular DNA genomes that replicate within the nuclei of infected cells. CPE due to the presence of anelloviruses have not been well described at present. Finally, primary cells can contain endogenous retroviruses and other viruses. For example, primary monkey kidney cells, which are used for the detection of paramyxoviruses and picornaviruses in many American diagnostic microbiology laboratories, can contain endogenous simian viruses that are either latent in the kidneys, or cause persistent but inapparent kidney infections in their hosts .
The work described in this manuscript resulted from a previous study of SV40 transcription in primate cells (J. Lednicky, unpublished). SV40 is a polyomavirus that was once referred to as “vacuolating agent” or “Simian vacuolating virus 40” because commonly studied SV40 strains induce the formation of cytoplasmic vacuoles late during infection of most permissive primate cells . A batch of primary human RPTEC that had been obtained for our previous transcription study of well-known vacuolating strains of SV40 proved unsuitable, as about 60% of the cells exhibited cytoplasmic vacuolation within 12 hours after they were seeded in flasks. Necrosis and apoptosis were also evident in some of the attached cells. Due to vacuolation and obvious cell deterioration, the RPTEC were rejected for our SV40 study. Nevertheless, as we often work with primary cells and continuously refine our research methodologies, we sought to determine a likely root cause(s) of the deterioration of the RPTEC to (a) Advance our understanding of primary cell culture technology, and (b) Explore whether proper biosafety practices were being observed. For example, might the RPTEC be contaminated with a significant pathogen best suited for work in biosafety level-3 or −4 laboratories?
We first tested whether vacuolation of the RPTEC stemmed from faulty media preparation. For example, vacuoles can form in Madin Darby Canine Kidney (MDCK) cells due to: (a) shortage of L-glutamine in the cell growth medium, (b) inappropriate addition of anti-fungal agents to the medium, (c) improper CO2 environment for the sodium bicarbonate concentration of the medium, (d) nutrient depletion of the medium, and (e) mycoplasma contamination . Faulty media formulation was ruled out as the root cause of the failure of this batch of RPTEC to thrive. Instead, based on the progressive formation of CPE, the results of our initial diagnostic tests, and our cumulative experience with cell culture , we predicted that adventitious agents were causing the rapid demise of our RPTEC cultures. DNA extracted from the RPTEC tested negative by PCR for mycoplasma species, and polyomaviruses SV40 and BK virus (BKV), suggesting none of these was causing vacuolation and/or cell deterioration. However, a single cause of the RPTEC deterioration was unlikely, as we detected 3 different human viruses in the RPTEC: Human cytomegalovirus (CMV), Human coronavirus NL63 (HCoV-NL63), and Human herpesvirus 6B (HHV-6B).
CMV, also known as Human herpesvirus-5 (HHV-5), (subfamily Betaherpesvirinae), is a double-stranded DNA virus that establishes lifelong persistence; it can remain latent in different human tissues and is known to infect renal tubular epithelial cells. A majority of humans are seropositive for CMV [24, 25]. Whereas CMV infections are typically asymptomatic in healthy humans, the virus can reactivate and cause disease in immunosuppressed patients, including those undergoing kidney transplantation. Indeed, CMV antigens and DNA are found in renal epithelial cells in kidneys of trauma victims examined during autopsy as well as in biopsies of renal allografts, indicating that these cells can harbor CMV in both healthy persons and allograft recipients [26, 27]. HCoV-NL63 is a single-stranded positive-sense RNA virus of the genus Alphacoronavirus (family Coronaviridae, order Nidovirales). First identified in 2003 from a child with bronchiolitis in the Netherlands, it is now recognized that HCoV-NL63 can cause upper and lower respiratory tract infections in humans, primarily in infants and the elderly [28–33]. Wild-type HCoV-NL63 is difficult or impossible to isolate from clinical specimens in continuous cell lines , although the prototype HCoV-NL63 strain was propagated in LLC-MK2 cells  and in primary, differentiated human bronchial-tracheal respiratory epithelial cells cultured at the air-liquid interface . There are at least three different HCoV-NL63 genotypes (A, B, and C) . HHV-6B is a double stranded DNA virus (subfamily Betaherpesvirinae, genus Roseolovirus) that infects up to 100% of humans and is the causative agent of exanthem subitum, which is also known as roseola infantum or sixth disease . After the primary infection, HHV-6B generally persists in latent form in T-lymphocytes and other cells. HHV-6B reactivation is common in transplant recipients, which can cause several clinical manifestations such as encephalitis, bone marrow suppression and pneumonitis .
The work presented herein serves as a reminder that biologicals (such as calf serum and cultured cells) can be contaminated with adventitious agents. The focus of this article is on the detection and isolation of HCoV-NL63, which to our knowledge, heretofore has not been reported in a natural infection of human kidney cells, or tested in vitro in primary human RPTEC.
Indications of more than one virus in contaminated RPTEC
Microscopy, 12 hr post-seed
Owl eye nuclei; enlarged cells
IFA, 48 hr post-seed
PCR, 48 hr post-seed
Bioactive agent release assay
Vacuolation 12 hpi, 37°C
Vacuolation 12 hpi, 37°C
Vacuolation 12 hpi, 37°C
Vacuolation 12 hpi, 37°C
C.R., Sw. & Vac.h 12 hpi, 37°C; cell death 48 hpi
Subcultures, 5 d post-seed of RPTEC
Vacuolation 12 hpi; CPE 6 dpib
CPE 7 dpid
Vacuolation 12 hpi; CPE 5 dpie
CPE 6 dpie
CPE 6 dpie
CPE 6 dpie
Vacuolation 12 hpi; CPE 6 dpib
C.R. Sw. & vac.h 12 hpi, 37°C; cell death 48 hpi
Subcultures, freeze-thaw 7d post-seed of RPTEC
CPE 6 dpib
CPE 7 dpid
CPE 5 dpie
CPE 6 dpie
CPE 6 dpie
CPE 5 dpie
CPE 6 dpie
No CPE 30 dpi
Moreover, CV-1, LLC-MK2, and Vero cells, which are cell lines derived from monkey kidneys, did not get vacuolated after 24 hrs incubation with BGM. Thus, no evidence of cytotoxicity due to BGM was uncovered. By 36 hrs post-seed, vacuoles were still present in RPTEC in BGM that had been boosted with additional L-glutamine, suggesting glutamine deficiency was not an issue.
Bioagent release assays
Immunofluorescence assay (IFA) and PCR for CMV
Some RPTEC from 48 hr cultures were positive for CMV by IFA (their nuclei were fluorescent), and DNA extracted and purified from the cells also tested positive for CMV by PCR (data not shown). However, the extracted DNA was PCR negative for human herpes virus (HHV)-1 and HHV-2, and polyomaviruses SV40 and BKV (Table 1).
Isolation of virus from live cells
Electron microscopy of contaminated RPTEC
Virus isolation from freeze-thawed RPTEC
Somewhat different results were obtained when the indicator cells of Table 1 were inoculated with freeze-thawed RPTEC lysate from 7-day old cultures instead of spent media from 5-day old RPTEC cultures. In contrast to previous findings, CPE were not observed in WI-38 cells at early times onto 30 days p.i. However, CPE were seen in LLC-MK2 cells starting 4 days p.i., and in other cells at later times (Table 1). As before, vacuolation was more pronounced at 37° than 34°C.
Since syncytia were observed, we focused PCR efforts on the detection of the viruses that we considered the most likely candidates: coronaviruses, human paramyxoviruses, and reoviruses (HHV-1 and −2 were already ruled out, section 3, above). We did not test for retroviruses, acknowledging that exogenous or endogenous retroviruses may have been causing syncytia in the cells. Extracted nucleic acids were tested by PCR or RT-PCR using assays designed to detect known human coronaviruses [33, 40–42], paramyxoviruses [43–45], and reoviruses .
Electron microscopy of HCoV-NL63 in LLC-MK2 cells
Molecular dataset, sequence alignment, and phylogenetic analysis
PCR detection of another herpesvirus in DNA from contaminated RPTEC
For more comprehensive analyses. PCR tests for herpesviruses that were not included in our previous assays (for HHV-3,-4,-6,-7, and −8) were performed on DNA extracted from RPTEC. A 151-bp amplicon was generated using nested primers for HHV-6 . Identity was confirmed by sequencing (data not shown).
Biotypes of plaque-purified HCoV-NL63/RPTEC/2004 compared to HCoV-NL63/Amsterdam-1
Growth of HCoV-NL63/RPTEC/2004- and -Amsterdam-1 in primary human kidney cells
Virus titers in primary human cells
The presence of CMV in the original batch of virus-contaminated RPTEC was not a surprise to us, as we have isolated CMV from frozen (−80°C) simian kidneys and from primary simian kidney cells (Lednicky, unpublished). We learned from the supplier that the donor of the virus-contaminated RPTEC of this study was seropositive for CMV. However, our batch of virus-contaminated RPTEC was not checked for the presence of CMV by the supplier (personal communication). As precedence for the presence of CMV in human kidney cells in vivo, it is known that reactivation of CMV in renal tubule epithelial cells can complicate kidney transplantation, leading to poor long-term graft function . The apparent complete inactivation of CMV by the freeze-thaw procedure we used was unexpected, as the process does not always completely inactivate CMV , but was nevertheless fortuitous, leading to observations resulting in the detection of HCoV-NL63. Then again, it may have inactivated other viruses in the RPTEC.
To our knowledge, ours is the first description of HCoV-NL63 in primary RPTEC. Overall, our observations of HCoV-NL63 growth in various cell lines appear consistent with literature reports. Growth of the virus in LLC-MK2 and Vero cells is well known [29, 33, 54]. The ability of the virus to form CPE in MDCK was previously described . The lack of HCoV-NL63 growth in human fibroblasts has been reported . In particular, MRC-5 cells, did not support the replication of HCoV-NL63 , and those cells are used interchangeably with WI-38 cells in American diagnostic virology laboratories for the isolation of respiratory viruses and CMV (both cell lines are derived from human fetal lung cells). Thus, it is not surprising that HCoV-NL63 does not replicate in WI-38 cells. Growth of HCoV-NL63 at 37°C has been reported and should not be a surprise [29, 49]. That HCoV-NL63 might induce vacuolation is not a surprise, as that is a common property of coronaviruses. It will be interesting to see if interaction with ganglioside GM1 is related to the vacuolation process, as reported for SV40 .
HCoV-NL63 replicated in HEK-293 cells, as does SARS-CoV [55, 56]. Both SARS-CoV and HCoV-NL63 can use angiotensin-converting enzyme 2 (ACE2) as a viral receptor , and ACE2 is expressed in kidneys , and may be reasons HCoV-NL63 was present in our batch of RPTEC and could infect HEK-293 cells. Replication of SARS-CoV in Mv1 Lu cells was previously reported , so perhaps it is not surprising that HCoV-NL63 does as well, if the viruses share receptor specificity, and Mv1 Lu cells contain the cellular machinery necessary for the replication of these viruses. However, the origin of HEK-293 is unclear, as the cells express neurofilament (NF) subunits NF-H, NF-L, NF-M, alpha-internexin, and other proteins found in neurons . Thus, HEK-293 may be of neuronal origin, and it will be interesting in the future to discern which neural and kidney cells support the replication of HCoV-NL63.
It is not clear why rapid cell swelling rounding, and vacuolation, followed by cell death, occurred in WI-38 cells. Our current hypothesis is that CMV was latent in the kidney cells of the donor of the RPTEC, and that the virus was reactivated during the initial harvest of cells from the donor’s kidney. We surmise that within our batch of RPTEC, that many of the cells had been inadvertently frozen when they were at an early stage of CMV infection. It is likely that the cells produced a large yield of CMV when they were brought out of cryopreservation, and that the high-titer CMV infected the permissive WI-38 at a high MOI, and this resulted in rapid killing of those cells. Since we were unprepared for such analyses, a quantitative enumeration of infectious CMV particles was not performed. We also suspect that CMV from the RPTEC had infected Vero, LLC-MK2, and CV-1 cells, but the infection was abortive , unlike the situation in WI-38 cells, which are permissive for that virus.
Finding that the HCoV-NL63 is similar to viruses from 2004 and 2005 is perhaps not surprising, as the RPTEC of this report were prepared from a donor and purchased (by us) that same year.
To our knowledge, HCoV-NL63 has not been reported in natural infections of human kidneys. The ability of HCoV-NL63 to replicate to high titers in primary RPTEC and HRE cells suggests that at least some human kidney cells are fully permissive for the virus. However, we are unable to resolve whether (a) The original batch of contaminated RPTEC were infected (naturally) with the virus prior to harvest, or (b) A worker with a respiratory infection accidentally contaminated the RPTEC during their initial preparation, or (c) The RPTEC were contaminated in our laboratory. We are unable to resolve the issue whether the cells were contaminated during preparation for many reasons, foremost being the company that sold the cells was merged with a different entity. It is unlikely that the RPTEC were infected in our laboratory, as we did not have HCoV-NL63 in our laboratory in 2004, and acquired HCoV-NL63/Amsterdam-1 only recently (Sept. 2012) so that we could compare the biotype of HCoV-NL63/RPTEC with that of Amsterdam-1. Moreover, our laboratory policy dictates that workers refrain from cell culture work when they have a respiratory tract infection. It is plausible (but we lack proof) that HCoV-NL63 may have been latent in the donor’s kidneys, a possibility consistent with the known biology of various coronaviruses that establish long-term but sub-clinical infections. Noteworthy, SARS-CoV, which shares the same ACE2 receptor as HCoV-NL63, has been associated with kidney disease [61–64]. SARS-CoV causes a systemic infection with viral shedding not only in respiratory secretions, but also in stool and urine [63, 65, 66]. Perhaps HCoV-NL63 is capable of causing systemic infections as well, though the severity is much less than that of SARS-CoV. A parallel to this notion is the finding that HCoV-NL63 replicates to high titers in CaCo-2 cells , which are derived from a human colon carcinoma. In April of 2012, a new coronavirus capable of causing severe acute respiratory infections of humans emerged in Jordan. The same coronavirus was isolated in the summer of 2012 from a patient with acute pneumonia and renal failure in Saudi Arabia [67, 68]. The new virus has been fully sequenced, classified as a group C β-coronavirus [69–71], and termed Middle East Respiratory Syndrome Coronavirus (MERS-CoV) by the Coronavirus Study Group of the International Committee on Taxonomy of Viruses (announced in J. Virology on May 15, 2013). Genetically, MERS-CoV is closely related to SARS-CoV, and is another example of a coronavirus associated with respiratory disease that can also infect kidney cells. The donor of the RPTEC of our study did not have kidney disease (otherwise, the cells would not have been harvested and sold for research purposes), suggesting a persistent, sub-clinical infection of the kidneys by HCoV-NL63 is more likely.
To what extent, if any, HHV-6B may have somehow modulated the growth of the other viruses in the RPTEC is unclear. Noteworthy, HHV-6B has also been reported in association with renal epithelial cells and kidney transplant rejection .
Lastly, whereas the virus-like particles of Figure 4C appear similar to those in an electron micrograph of SARS-CoV in kidney tissue , we have no formal proof that they are in fact HCoV-NL63 and may be another virus we did not identify in our work. Taken together, our findings are a reminder that human-derived biologicals should always be considered as potential sources of infectious agents. Moreover, our findings raise the possibility of kidney involvement during the course of infection with HCoV-NL63.
Cells and cell-growth media
Cryopreserved primary human RPTEC were obtained from a commercial source in the USA. BGM, supplements, and growth factors [fetal bovine serum, insulin, transferrin, triiodothyonine (T3), human recombinant epidermal growth factor, hydrocortisone, epinephrine, gentamicin sulfate, and amphotericin-B] were concurrently obtained as a kit from the RPTEC supplier. The RPTEC were first seeded onto four T25 flasks and manipulated following instructions included with the kit. MDCK-London cells were a gift from Dr. Gary Heil, University of Florida. Cell lines A549 (CCL-185), BHK-21 (CCL-10), CaCo-2 (HTB-37), CV-1 (CCL-70), HEK-293 (CRL-1573), LLC-MK2 (CCL-7), MDCK, (CCL-34), Mv1 Lu (CCL-64), NIH/3 T3 (CRL-1658), Vero E6 (CRL-1586), and WI-38 (CCL-75) were obtained from the ATCC (Manassas, VA), and along with MDCK-London cells, were propagated as monolayers at 37°C and 5% CO2 in Dulbecco's Modified Eagle's Medium (DMEM) (Mediatech, Inc., Manassas, VA) or Eagle’s Minimal Essential Medium (EMEM) (Invitrogen Corp., Carlsbad, CA), as appropriate per cell line. DMEM and EMEM were initially supplemented with 2 mM L-Glutamine, which was later substituted with 2 mM L-Alanyl-L-Glutamine (GlutaMAX™, Invitrogen Corp.). Both DMEM and EMEM were supplemented with antibiotics [PSN; 50 μg/ml penicillin, 50 μg/ml streptomycin, 100 μg/ml neomycin (Invitrogen Corp.)], and 10% (v/v) low IgG, heat-inactivated gamma-irradiated fetal bovine serum (HyClone, Logan, UT). Additionally, sodium pyruvate (Invitrogen Corp.) and non-essential amino acids (Hyclone) were added to EMEM., with the exception: EMEM formulated with calf serum (HyClone) instead of FBS was used for NIH/3 T3 cells. Before seed stocks were prepared, the cell lines were propagated in growth media with plasmocin (Invivogen, San Diego, CA) for 2 weeks to reduce the chances of mycoplasma contamination. Next, the cell lines were incubated for a minimum of 2 weeks in the absence of antibiotics to determine whether fast-growing microbial contaminants were present or abnormal morphological changes would occur (associated with intracellular mycoplasma). Following 2–3 weeks of propagation without antibiotics, the plasmocin-treated cell lines and RPTEC cells were tested by PCR for the presence of mycoplasma DNA using a Takara PCR Mycoplasma Detection kit (Fisher Scientific, Pittsburgh, PA) . The cells tested negative for mycoplasma. An independent laboratory (at the University of Florida) confirmed that the stock of LLC-MK2 cells that was used for the isolation of HCoV-NL63 in this manuscript was negative for human respiratory viruses including human coronaviruses 229E, HKU1, OC43, and NL63 using a GenMark multiplex respiratory PCR eSensor XT-8 Respiratory Viral Panel (eSensor RVP; GenMark Diagnostics, Inc., Carlsbad, CA).
Glutamine deficiency test
Fresh L-glutamine was added to BGM in a 24 hr RPTEC culture and the cells observed every six hrs for one day to assess the effect on cell morphology, vacuolation, and viability.
BGM cytotoxicity assay
Complete, freshly prepared BGM was substituted for DMEM in subconfluent cultures of CV-1, LLC-MK2, MDCK, Vero, and WI-38 cells, and the cells incubated at 37°C and observed every 12 hours over 3 days for morphological changes or cell death as evidence of cytotoxicity.
Bioactive agent release assay
To find out whether the RPTEC were releasing a bioactive agent, spent BGM from a 24 hr RPTEC culture was equally subdivided and added to subconfluent CV-1, HEK-293, LLC-MK2, Vero E6, and WI-38 cells in T-25 flasks. These particular cell lines were chosen on the assumption that a virus growing in RPTEC would preferentially infect primate over non-primate cells. After inoculation, the cells were incubated at 37°C (the same temperature used for RPTEC) and observed for morphological aberrations over 48 hrs.
Detection of cytomegalovirus by an indirect immunofluorescence assay (IFA)
A standard cytospin procedure was used to deposit RPTEC from a 48 hr culture onto a glass slide. IFA was performed using a commercial kit with a primary antibody directed against a CMV immediate early protein, and a secondary antibody that was labeled with fluorescein isothiocyanate (LIGHT DIAGNOSTICS™ CMV IFA Kit, Millipore, Billerica, MA).
Electron microscopy of virus-contaminated RPTEC
The BGM of a five day RPTEC culture was replaced with fresh ice-cold cacodylate-buffered 4% gluteraldehyde (pH 7.2). After 2 hrs at room temperature, the fixed cells were scraped free using a cell scraper, and pelleted by centrifugation at 8,000 x g for 10 minutes. The fixative was removed, and the cell pellet resuspended with cold fixative to a final volume of 500 μl, then stored overnight at 4°C. The fixed cells were post-fixed with osmium tetroxide, stained with uranyl acetate, embedded in Spurr’s embedding medium, then thin-sectioned. The thin sections were stained with uranyl acetate and lead citrate and transmission electron microscopy performed using a Hitachi H-600.
Isolation of adventitious viruses from five-day old contaminated RPTEC cultures
Five days after being seeded, about 50% of the RPTEC had completely deteriorated, whereupon spent BGM media was added to 2 groups of subconfluent A549, BHK-21, CV-1, HEK-293, LLC-MK2, MDCK, MDCK-London, Mv1 Lu, NIH/3 T3, Vero E6, and WI-38 cells in complete growth media, and to 2 groups of LLC-MK2 and MDCK and Mv1 Lu cells in serum-free media containing L-1-tosylamide-2-phenylethyl chloromethyl ketone (TPCK)-treated trypsin. The TPCK-trypsin was at a final concentration of 2 μg/mL (MDCK and MDCK-London cells) or 0.2 μg/mL (LLC-MK2 and Mv1 Lu). For each group, 1 set was incubated at 37°C, the other at 34°C (incubation at 2 different temperatures is standard in our laboratory, as many of the respiratory viruses we work with preferentially replicate at temperatures lower than 37°C). TPCK-trypsin in serum-free media was used to facilitate the isolation of influenza and other viruses that require protease cleavage of some viral component for infectivity. After inoculation, the cells were re-fed every 3 days with 3% serum media or serum-free media with trypsin for long-term (up to 30 day) observations.
Isolation of adventitious viruses from frozen RPTEC cell-lysates
At day 7 post-seed, only about 10% of the RPTEC remained attached to the flask, a majority of which were vacuolated and showed other signs of CPE. To facilitate the isolation of viruses other than CMV, the cells were scraped free and transferred along with the spent BGM into a sterile 50 mL polypropylene centrifuge tube, and frozen at −20°C for one week (this step reduces the number of viable CMV virions by a factor of many logs, since CMV loses viability when stored at −20°C) ; [J. Lednicky, unpublished]. Next, the frozen tube of scraped RPTEC was freeze-thawed three times, alternating between freezing at −20°C for 12 hrs and a 30 minute thaw at room temperature, as an additional measure to further reduce the number of viable CMV particles. After the third thaw, an aliquot was tested using the cells and methods of section 2.5 above, and the remainder frozen at −80°C for retrospective analyses.
PCR and RT-PCR for the detection of viruses
Intracellular DNA was purified from a 48 hr RPTEC culture using a QIAamp DNA mini kit (Qiagen, Valencia, CA) and tested by PCR for CMV, HHV-1 and −2, and polyomaviruses SV40 and BKV. Total RNA was purified from a freeze-thawed seven-day old RPTEC culture supernatant using a QIAamp Viral RNA kit (QIAGEN). The primers and conditions that were used for PCR-based detection of viruses were based on published literature and will be provided upon request. Since syncytia were formed by the second virus (not CMV) that we were attempting to identify, PCR efforts were focused on human herpes, paramyxo (measles, mumps, metapneumovirus, parainfluenza viruses 1–5, respiratory syncytial virus), and coronaviruses.
RT-PCR for RNA virus screens was performed with Omniscript reverse transcriptase (Qiagen) followed by PCR with Hotshot TAQ (New England Biolabs, Ipswich, MA) 68°C. HCoV-NL63 was first detected using a pancoronavirus RT-PCR assay for the viral polymerase gene with primer pair Cor-FW and Cor-RV , followed by sequencing of the 251 bp amplicon. That was accomplished using Cor-RV for cDNA synthesis (with reverse transcription performed for 1 hr at 37°C), and PCR performed as: initial denaturation step: 94°C (1.5 min); 30 cycles of 94°C (20 sec), 48°C (30 sec), 68°C (30 sec); terminal extension step at 68°C (3.5 min); 4°C ∞. For confirmation, primer pairs N5-PCR1 and N3-PCR1  and repSZ-1, and repSZ-3  were used with PCR parameters similar to those for Cor-FW and Cor-RV, and the resulting amplicons sequenced. N5-PCR1 and N3-PCR1 amplify a 314 bp amplicon from the HCoV-NL63 nucleocapsid region. N3-PCR1 was used to generate cDNA, and PCR performed at an annealing temperature of 46°C. Following cDNA synthesis primed with repSZ-RT , primer pair repSZ-1, and repSZ-3 amplify a 237 bp amplicon from the HCoV-NL63 ORF1b region at a PCR annealing temperature of 46°C.
Electron microscopy of LLC-MK2 cells infected with HCoV-NL63 from RPTEC
LLC-MK2 cells that were RT-PCR positive for HCoV-NL63 were trypsinized to detach them from the growing surface of a T75 flask, pelleted, and the pellet resuspended in ice-cold 4% paramormaldehyde, 2% gluteraldehyde, in 0.1 M sodium cacodylate, pH 7.2. They were subsequently analyzed as described above.
Sequencing of HCoV-NL63 genome
Targeted HCoV-NL63/RPTEC/2004 sequences were RT-PCR-amplified from purified RNA using a genome walking strategy. Briefly, overlapping primers described by H. Geng et al. (GenBank JX524171) and others [33, 42] were used to obtain the viral sequence. AccuScript High Fidelity Reverse Transcriptase (Agilent Technologies, Inc., Santa Clara, CA) was used for first-strand cDNA synthesis in the presence of SUPERase-In RNase inhibitor (Ambion). PCR was performed using Phusion Polymerase (New England Biolabs) with denaturation steps performed at 98°C. The 3′ and 5′ ends of HCoV-NL63/RPTEC/2004 were determined from vRNA using a RACE (rapid amplification of cDNA ends) kit (RLM RACE, Ambion, Austin, TX) following the manufacturer’s instructions. Sequences were analyzed using an Applied Biosystem 3130 DNA analyzer by using BigDye Terminator (v. 3.1) chemistry and the same primers used for amplifications.
Molecular dataset, sequence alignment, and phylogenetic analysis
The genomic sequence for isolate NL63/RPTEC/2004/1 was combined with other representative NL63 genomic sequences  available in GenBank (ncbi.nlm.nih.gov/genbank/index.html) to build the final dataset. Full genome alignments were performed using Mafft 5.8  followed by minor manual adjustments in ClustalW . The E-INS-I alignment strategy was used with the following parameters: scoring matrix (BLOSUM62), gap open penalty (1.53), and offset value (0). The aligned dataset was imported into jModelTest version 0.1.1  and the Akaike information criterion (AIC) was used to select a best-fit model of evolution for phylogenetic analysis. Phylogenetic trees were constructed using MrBayes 3.1.2 . The Markov chain was run for a maximum of 10 million generations, with a stopping rule implemented so that the analysis would halt when the average deviation of the split frequencies was < 0.01. Four independent analyses were conducted, each with 1 cold and 3 heated chains with the default heating parameter (temperature = 0.2). Every 1000 generations were sampled and the first 25% of MCMC samples discarded as burn-in.
HCoV-NL63/Amsterdam-1 was obtained from the Biodefense and Emerging Infections Research Resources Repository (BEI Resources, Manassas, VA).
Plaque assays were performed following the procedures outlines in references 39 and 50.
New batch of primary human kidney cells
Primary human kidney cells were obtained from Lonza, Inc. (Allendale, NJ). The cells chosen were: Renal Cortex Epithelial Cells (HRCE) (Cat #: CC-2554, Lot #: 1 F2266, cryopreserved 13 Oct 2010), Human Renal Epithelial Cells (HRE) (Cat #: CC-2556, Lot #: 5 F1314, cryopreserved 19 Oct 2005), and Renal Proximal Tubule Epithelial Cells (RPTEC) (Cat #: CC-2553, Lot #: 0000203150, cryopreserved 21 Dec 2001). The primary cells were grown in Clonetics renal epithelial basal medium (REBM, Lonza, Inc.) (Catalog No: CC-3191, Lot #: 0000345705) with Clonetics REBM SingleQuots supplements (fetal bovine serum, gentamycin sulfate, amphotericin B, insulin, recombinant human epidermal growth factor, transferrin, hydrocortisone, epinephrine, and triiodothyronine).
Part of this work, including electron microscopy, was performed when the corresponding author was at the Dept of Pathology at the Loyola University Medical Center (LUMC), Maywood, Illinois. At LUMC, Linda Fox provided excellent assistance with electron microscopy. Some of this work was performed in partial fulfillment of internship requirements for EM and MCL. The authors thank Dr. Gary Heil for MDCK-London cells. Electron microscopy at the University of Florida was performed by Karen Kelley.
This work was financed by intramural funds made available to J. Lednicky.
- Lednicky JA, Wyatt DE: The Art of animal cell culture for virus isolation. Biomedical tissue culture. Edited by: Ceccherini-Nell L, Zagreb MB. Croatia: Janeza Trdine 9, 51000 Rijeka, InTech; 2012:151–178. ISBN 978-953-51.Google Scholar
- Bolin SR, Matthews PJ, Ridpath JF: Methods for detection and frequency of contamination of fetal calf serum with bovine viral diarrhea virus and antibodies against bovine viral diarrhea virus. J Vet Diagn Invest. 1991, 3: 199-203. 10.1177/104063879100300302.PubMedView ArticleGoogle Scholar
- Falcone E, Tollis M, Conti G: Bovine viral diarrhea disease associated with a contaminated vaccine. Vaccine. 1999, 18: 387-388.PubMedView ArticleGoogle Scholar
- Harasawa R, Mizusawa H: Demonstration and genotyping of pestivirus RNA from mammalian cell lines. Microbiol Immunol. 1995, 39: 979-985.PubMedView ArticleGoogle Scholar
- Levings RL, Wessman SJ: Bovine viral diarrhea virus contamination of nutrient serum, cell cultures and viral vaccines. Dev Biol Stand. 1991, 75: 177-181.PubMedGoogle Scholar
- Vilcek S: Identification of pestiviruses contaminating cell lines and fetal calf sera. Acta Virol. 2001, 45: 81-86.PubMedGoogle Scholar
- Schuurman R, van Steenis B, Sol C: Bovine polyomavirus, a frequent contaminant of calf serum. Biologicals. 1991, 19: 265-270. 10.1016/S1045-1056(05)80014-4.PubMedView ArticleGoogle Scholar
- van der Noordaa J, Sol CJ, Schuurman R: Bovine polyomavirus, a frequent contaminant of calf sera. Dev Biol Stand. 1999, 99: 45-47.PubMedGoogle Scholar
- Allander T, Emerson SU, Engle RE, Purcell RH, Bukh J: A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species. Proc Natl Acad Sci USA. 2001, 98: 11609-11614. 10.1073/pnas.211424698.PubMedPubMed CentralView ArticleGoogle Scholar
- Lau SK, Woo PC, Tse H, Fu CT, Au WK, Chen XC, Tsoi HW, Tsang TH, Chan JS, Tsang DN, et al: Identification of novel porcine and bovine parvoviruses closely related to human parvovirus 4. J Gen Virol. 2008, 89: 1840-1848. 10.1099/vir.0.2008/000380-0.PubMedView ArticleGoogle Scholar
- Nettleton PF, Rweyemamu MM: The association of calf serum with the contamination of BHK21 clone 13 suspension cells by a parvovirus serologically related to the minute virus of mice (MVM). Arch Virol. 1980, 64: 359-374. 10.1007/BF01320621.PubMedView ArticleGoogle Scholar
- Egyed L: Replication of bovine herpesvirus type 4 in human cells in vitro. J Clin Microbiol. 1998, 36: 2109-2111.PubMedPubMed CentralGoogle Scholar
- Egyed L: Bovine herpesvirus type 4: a special herpesvirus (review article). Acta Vet Hung. 2000, 48: 501-513.PubMedView ArticleGoogle Scholar
- Fong CK, Landry ML: An adventitious viral contaminant in commercially supplied A549 cells: identification of infectious bovine rhinotracheitis virus and its impact on diagnosis of infection in clinical specimens. J Clin Microbiol. 1992, 30: 1611-1613.PubMedPubMed CentralGoogle Scholar
- Michalski FJ, Dietz A, Hsiung GD: Growth characteristics of bovine herpesvirus 1 (infectious bovine rhinotracheitis) in human diploid cell strain WI-38. Proc Soc Exp Biol Med. 1976, 151: 407-410. 10.3181/00379727-151-39221.PubMedView ArticleGoogle Scholar
- Hattermann K, Roedner C, Schmitt C, Finsterbusch T, Steinfeldt T, Mankertz A: Infection studies on human cell lines with porcine circovirus type 1 and porcine circovirus type 2. Xenotransplantation. 2004, 11: 284-294. 10.1111/j.1399-3089.2004.00134.x.PubMedView ArticleGoogle Scholar
- Ma H, Shaheduzzaman S, Willliams DK, Gao Y, Khan AS: Investigations of porcine circovirus type 1 (PCV1) in vaccine-related and other cell lines. Vaccine. 2011, 29: 8429-8437. 10.1016/j.vaccine.2011.07.123.PubMedView ArticleGoogle Scholar
- Marcus-Sekura C, Richardson JC, Harston RK, Sane N, Sheets RL: Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products. Biologicals. 2011, 39: 359-369. 10.1016/j.biologicals.2011.08.003.PubMedPubMed CentralView ArticleGoogle Scholar
- Teixeira TF, Dezen D, Cibulski SP, Varela AP, Holz CL, Franco AC, Roehe PM: Torque teno sus virus (TTSuV) in cell cultures and trypsin. PLoS One. 2011, 6: e17501-10.1371/journal.pone.0017501.PubMedPubMed CentralView ArticleGoogle Scholar
- Tischer I, Bode L, Apodaca J, Timm H, Peters D, Rasch R, Pociuli S, Gerike E: Presence of antibodies reacting with porcine circovirus in sera of humans, mice, and cattle. Arch Virol. 1995, 140: 1427-1439. 10.1007/BF01322669.PubMedView ArticleGoogle Scholar
- Lednicky JA, Waltzek TB, Halpern MD, Hamilton SB: Comparative analysis of the full-length genome sequence of a clinical isolate of Human parainfluenza virus 4B. Scientifica. 2012, 2012: e871201-http://dx.doi.org/10.6064/2012/871201,View ArticleGoogle Scholar
- Magaldi TG, Buch MH, Murata H, Erickson KD, Neu U, Garcea RL, Peden K, Stehle T, DiMaio D: Mutations in the GM1 binding site of simian virus 40 VP1 alter receptor usage and cell tropism. J Virol. 2012, 86: 7028-7042. 10.1128/JVI.00371-12.PubMedPubMed CentralView ArticleGoogle Scholar
- My MDCK cells (ATCC® CCL-34) have developed vacuoles. What is wrong?. 2012, http://atcc.custhelp.com/app/answers/detail/a_id/443/~/atcc%E2%AE-ccl-34%3A-vacuoles-in-mdck-cells,
- Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ: Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis. 2006, 43: 1143-1151. 10.1086/508173.PubMedView ArticleGoogle Scholar
- Zhang LJ, Hanff P, Rutherford C, Churchill WH, Crumpacker CS: Detection of human cytomegalovirus DNA, RNA, and antibody in normal donor blood. J Infect Dis. 1995, 171: 1002-1006. 10.1093/infdis/171.4.1002.PubMedView ArticleGoogle Scholar
- Ulrich W, Schlederer MP, Buxbaum P, Stummvoll H, Rockenschaub S, Kovarik J, Krisch I: The histopathologic identification of CMV infected cells in biopsies of human renal allografts. An evaluation of 100 transplant biopsies by in situ hybridization. Pathol Res Pract. 1986, 181: 739-745. 10.1016/S0344-0338(86)80050-4.PubMedView ArticleGoogle Scholar
- Hendrix RM, Wagenaar M, Slobbe RL, Bruggeman CA: Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. J Clin Pathol. 1997, 50: 59-63. 10.1136/jcp.50.1.59.PubMedPubMed CentralView ArticleGoogle Scholar
- Abdul-Rasool S, Fielding BC: Understanding human coronavirus HCoV-NL63. Open Virol J. 2010, 4: 76-84. 10.2174/1874357901004010076.PubMedPubMed CentralView ArticleGoogle Scholar
- Fouchier RA, Hartwig NG, Bestebroer TM, Niemeyer B, de Jong JC, Simon JH, Osterhaus AD: A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci USA. 2004, 101: 6212-6216. 10.1073/pnas.0400762101.PubMedPubMed CentralView ArticleGoogle Scholar
- Leung TF, Li CY, Lam WY, Wong GW, Cheuk E, Ip M, Ng PC, Chan PK: Epidemiology and clinical presentations of human coronavirus NL63 infections in hong kong children. J Clin Microbiol. 2009, 47: 3486-3492. 10.1128/JCM.00832-09.PubMedPubMed CentralView ArticleGoogle Scholar
- Pyrc K, Berkhout B, van der Hoek L: The novel human coronaviruses NL63 and HKU1. J Virol. 2007, 81: 3051-3057. 10.1128/JVI.01466-06.PubMedPubMed CentralView ArticleGoogle Scholar
- van der Hoek L, Pyrc K, Berkhout B: Human coronavirus NL63, a new respiratory virus. FEMS Microbiol Rev. 2006, 30: 760-773. 10.1111/j.1574-6976.2006.00032.x.PubMedView ArticleGoogle Scholar
- van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC, Wertheim-van Dillen PM, Kaandorp J, Spaargaren J, Berkhout B: Identification of a new human coronavirus. Nat Med. 2004, 10: 368-373. 10.1038/nm1024.PubMedView ArticleGoogle Scholar
- Dominguez SR, Sims GE, Wentworth DE, Halpin RA, Robinson CC, Town CD, Holmes KV: Genomic analysis of 16 Colorado human NL63 coronaviruses identifies a New genotype, high sequence diversity in the N-terminal domain of the spike gene, and evidence of recombination. J Gen Virol. 2012, 93: 2387-2398. 10.1099/vir.0.044628-0.PubMedPubMed CentralView ArticleGoogle Scholar
- Banach B, Orenstein JM, Fox LM, Randell SH, Rowley AH, Baker SC: Human airway epithelial cell culture to identify new respiratory viruses: coronavirus NL63 as a model. J Virol Methods. 2009, 156: 19-26. 10.1016/j.jviromet.2008.10.022.PubMed CentralView ArticleGoogle Scholar
- Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T: Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet. 1988, 1: 1065-1067.PubMedView ArticleGoogle Scholar
- Yoshikawa T: Human herpesvirus 6 infection in hematopoietic stem cell transplant patients. Br J Haematol. 2004, 124: 421-432. 10.1046/j.1365-2141.2003.04788.x.PubMedView ArticleGoogle Scholar
- Hodinka RL: Human cytomegalovirus. Manual of clinical microbiology. Edited by: Murray PR. 2007, Washington, D.C: ASM Press, 1549-1563. 9Google Scholar
- Smith JD, de Harven E: Herpes simplex virus and human cytomegalovirus replication in WI-38 cells. III. Cytochemical localization of lysosomal enzymes in infected cells. J Virol. 1978, 26: 102-109.PubMedPubMed CentralGoogle Scholar
- de Souza Luna LK, Heiser V, Regamey N, Panning M, Drexler JF, Mulangu S, Poon L, Baumgarte S, Haijema BJ, Kaiser L, Drosten C: Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray. J Clin Microbiol. 2007, 45: 1049-1052. 10.1128/JCM.02426-06.PubMedPubMed CentralView ArticleGoogle Scholar
- Drosten C, Günther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, et al: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003, 348: 1967-1976. 10.1056/NEJMoa030747.PubMedView ArticleGoogle Scholar
- Moës E, Vijgen L, Keyaerts E, Zlateva K, Li S, Maes P, Pyrc K, Berkhout B, van der Hoek L, van Ranst M: A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect Dis. 2005, 5: 6-10.1186/1471-2334-5-6.PubMedPubMed CentralView ArticleGoogle Scholar
- Rubinas TC, Carey RB, Kampert MC, Alkan S, Lednicky JA: Fatal hemorrhagic pneumonia concomitant with Chlamydia pneumoniae and parainfluenza virus 4 infection. Arch Pathol Lab Med. 2004, 128: 640-644.PubMedGoogle Scholar
- Tong S, Chern SW, Li Y, Pallansch MA, Anderson LJ: Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxoviruses. J Clin Microbiol. 2008, 46: 2652-2658. 10.1128/JCM.00192-08.PubMedPubMed CentralView ArticleGoogle Scholar
- van Boheemen S, Bestebroer TM, Verhagen JH, Osterhaus AD, Pas SD, Herfst S, Fouchier RA: A family-wide RT-PCR assay for detection of paramyxoviruses and application to a large-scale surveillance study. PLoS One. 2012, 7: e34961-10.1371/journal.pone.0034961.PubMedPubMed CentralView ArticleGoogle Scholar
- Ouattara LA, Barin F, Barthez MA, Bonnaud B, Roingeard P, Goudeau A, Castelnau P, Vernet G, Paranhos-Baccalà G, Komurian-Pradel F: Novel human reovirus isolated from children with acute necrotizing encephalopathy. Emerg Infect Dis. 2011, 17: 1436-1444.PubMedPubMed CentralGoogle Scholar
- Orenstein JM, Banach B, Baker SC: Morphogenesis of coronavirus HCoV-NL63 in cell culture: a transmission electron microscopic study. Open Infect Dis J. 2008, 2: 52-58.PubMedPubMed CentralView ArticleGoogle Scholar
- Hall CB, Long CE, Schnabel KC, Caserta MT, McIntyre KM, Costanzo MA, Knott A, Dewhurst S, Insel RA, Epstein LG: Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med. 1994, 331: 432-438. 10.1056/NEJM199408183310703.PubMedView ArticleGoogle Scholar
- Herzog P, Drosten C, Muller MA: Plaque assay for human coronavirus NL63 using human colon carcinoma cells. Virol J. 2008, 5: e138-10.1186/1743-422X-5-138.View ArticleGoogle Scholar
- Donaldson EF, Yount B, Sims AC, Burkett S, Pickles RJ, Baric RS: Systematic assembly of a full-length infectious clone of human coronavirus NL63. J Virol. 2008, 82: 11948-11957. 10.1128/JVI.01804-08.PubMedPubMed CentralView ArticleGoogle Scholar
- Dijkman R, Jebbink MF, Deijs M, Milewska A, Pyrc K, Buelow E, van der Bijl A, van der Hoek L: Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63. J Gen Virol. 2012, 93: 1924-1929. 10.1099/vir.0.043919-0.PubMedView ArticleGoogle Scholar
- Li YT, Emery VC, Surah S, Jarmulowicz M, Sweny P, Kidd IM, Griffiths PD, Clark DA: Extensive human cytomegalovirus (HCMV) genomic DNA in the renal tubular epithelium early after renal transplantation: relationship with HCMV DNAemia and long-term graft function. J Med Virol. 2010, 82: 85-93. 10.1002/jmv.21662.PubMedView ArticleGoogle Scholar
- Maschmann J, Hamprecht K, Weissbrich B, Dietz K, Jahn G, Speer CP: Freeze-thawing of breast milk does not prevent cytomegalovirus transmission to a preterm infant. Arch Dis Child Fetal Neonatal Ed. 2006, 91: F288-290. 10.1136/adc.2004.050625.PubMedPubMed CentralView ArticleGoogle Scholar
- Schildgen O, Jebbink MF, de Vries M, Pyrc K, Dijkman R, Simon A, Muller A, Kupfer B, van der Hoek L: Identification of cell lines permissive for human coronavirus NL63. J Virol Methods. 2006, 138: 207-210. 10.1016/j.jviromet.2006.07.023.PubMedView ArticleGoogle Scholar
- Kaye M, Druce J, Tran T, Kostecki R, Chibo D, Morris J, Catton M, Birch C: SARS-associated coronavirus replication in cell lines. Emerg Infect Dis. 2006, 1: 128-133.View ArticleGoogle Scholar
- Spiegel M, Weber F: Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus. Virol J. 2006, 3: 17-10.1186/1743-422X-3-17.PubMedPubMed CentralView ArticleGoogle Scholar
- Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout B, Pohlmann S: Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci USA. 2005, 102: 7988-7993. 10.1073/pnas.0409465102.PubMedPubMed CentralView ArticleGoogle Scholar
- Boehm M, Nabel EG: Angiotensin-converting enzyme 2–a new cardiac regulator. N Engl J Med. 2002, 347: 1795-1797. 10.1056/NEJMcibr022472.PubMedView ArticleGoogle Scholar
- Mossel EC, Huang C, Narayanan K, Makino S, Tesh RB, Peters CJ: Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication. J Virol. 2005, 79: 3846-3850. 10.1128/JVI.79.6.3846-3850.2005.PubMedPubMed CentralView ArticleGoogle Scholar
- Shaw G, Morse S, Ararat M, Graham FL: Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 2002, 16: 869-871.PubMedGoogle Scholar
- Chu KH, Tsang WK, Tang CS, Lam MF, Lai FM, To KF, Fung KS, Tang HL, Yan WW, Chan HW, et al: Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int. 2005, 67: 698-705. 10.1111/j.1523-1755.2005.67130.x.PubMedView ArticleGoogle Scholar
- Farcas GA, Poutanen SM, Mazzulli T, Willey BM, Butany J, Asa SL, Faure P, Akhavan P, Low DE, Kain KC: Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis. 2005, 191: 193-197. 10.1086/426870.PubMedView ArticleGoogle Scholar
- Gu J, Gong E, Zhang B, Zheng J, Gao Z, Zhong Y, Zou W, Zhan J, Wang S, Xie Z, et al: Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005, 202: 415-424. 10.1084/jem.20050828.PubMedPubMed CentralView ArticleGoogle Scholar
- To KF, Tong JH, Chan PK, Au FW, Chim SS, Chan KC, Cheung JL, Liu EY, Tse GM, Lo AW, et al: Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. J Pathol. 2004, 202: 157-163. 10.1002/path.1510.PubMedView ArticleGoogle Scholar
- Hung IF, Cheng VC, Wu AK, Tang BS, Chan KH, Chu CM, Wong MM, Hui WT, Poon LL, Tse DM, et al: Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis. 2004, 10: 1550-1557. 10.3201/eid1009.040058.PubMedPubMed CentralView ArticleGoogle Scholar
- Yam WC, Chan KH, Poon LL, Guan Y, Yuen KY, Seto WH, Peiris JS: Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. J Clin Microbiol. 2003, 41: 4521-4524. 10.1128/JCM.41.10.4521-4524.2003.PubMedPubMed CentralView ArticleGoogle Scholar
- Corman V, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, van Boheemen S, Gopal R, Ballhause M, Bestebroer T, et al: Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012, 17 (39): 20285-PubMedGoogle Scholar
- Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012, 367: 1814-1820. 10.1056/NEJMoa1211721.PubMedView ArticleGoogle Scholar
- Chan JFW, Li KSM, To KKW, Cheng VCC, Chen H, Yuen K-Y: Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?. J Infect. 2012, 65: 477-489. 10.1016/j.jinf.2012.10.002.PubMedView ArticleGoogle Scholar
- van Boheemen S, De Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus ADME, Haagmans BL, Gorbalenya AE, Snijder EJ, Fouchier RAM: Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio. 2012, 3 (6): e00473-12.PubMedPubMed CentralView ArticleGoogle Scholar
- Woo PC, Lau SK, Li KS, Tsang AK, Yuen K-Y: Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5. Emerg Microb Infect. 2012, 1: e35-10.1038/emi.2012.45.View ArticleGoogle Scholar
- Okuno T, Higashi K, Shiraki K, Yamanishi K, Takahashi M, Kokado Y, Ishibashi M, Takahara S, Sonoda T, Tanaka K, et al: Human herpesvirus 6 infection in renal transplantation. Transplantation. 1990, 49: 519-522. 10.1097/00007890-199003000-00009.PubMedView ArticleGoogle Scholar
- Katoh K, Kuma K, Toh H, Miyata T: MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. 2005, 33: 511-518. 10.1093/nar/gki198.PubMedPubMed CentralView ArticleGoogle Scholar
- Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22: 4673-4680.73. 10.1093/nar/22.22.4673.PubMedPubMed CentralView ArticleGoogle Scholar
- Posada D: jModelTest: phylogenetic model averaging. Mol Biol Evol. 2008, 25: 1253-1256. 10.1093/molbev/msn083.PubMedView ArticleGoogle Scholar
- Huelsenbeck JP, Ronquist F: MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics. 2001, 17: 754-755. 10.1093/bioinformatics/17.8.754.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.